Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari-Anne Gall

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Diabetes Technology & Therapeutics|July 10, 2007
Delivering needle-free insulin using AERx iDMS (insulin diabetes management system) technologyPer Wollmer, Thomas R Pieber, Mari-Anne Gall, et al.
Ugeskrift for Laeger|February 14, 2009
[Mannose-binding lectin and mortality in patients with type 2 diabetes mellitus--secondary publication]Troels Krarup Hansen, Mari-Anne Gall, Lise Tarnow, et al.
Journal of Diabetes|April 10, 2016
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 TrialShinji Taneda, Jacob Hyllested-Winge, Mari-Anne Gall, et al.
Diabetes Care|October 28, 2003
Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetesThomas Danne, Kerstin Lüpke, Kerstin Walte, et al.
Diabetes Care|July 8, 2010
Vitamin D levels and mortality in type 2 diabetesChristel Joergensen, Mari-Anne Gall, Anne Schmedes, et al.
Diabetes Research and Clinical Practice|January 3, 2012
High YKL-40 levels predict mortality in patients with type 2 diabetesFrederik Persson, Camilla Noelle Rathcke, Mari-Anne Gall, et al.
Diabetes Care|October 9, 2010
Osteoprotegerin and mortality in type 2 diabetic patientsHenrik Reinhard, Maria Lajer, Mari-Anne Gall, et al.
Diabetes|March 28, 2002
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of deathCoen D A Stehouwer, Mari-Anne Gall, Jos W R Twisk, et al.
Obstetrics and Gynecology|September 5, 2024
Glycemic Control and Risk of Congenital Malformations in Women With Type 1 DiabetesIda Holte Thorius, Janne Petersen, Lise Lotte N Husemoen, et al.
Archives of Internal Medicine|October 13, 2006
Mannose-binding lectin and mortality in type 2 diabetesTroels Krarup Hansen, Mari-Anne Gall, Lise Tarnow, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Diabetes Technology & Therapeutics|July 10, 2007
Delivering needle-free insulin using AERx iDMS (insulin diabetes management system) technologyPer Wollmer, Thomas R Pieber, Mari-Anne Gall, et al.
Ugeskrift for Laeger|February 14, 2009
[Mannose-binding lectin and mortality in patients with type 2 diabetes mellitus--secondary publication]Troels Krarup Hansen, Mari-Anne Gall, Lise Tarnow, et al.
Journal of Diabetes|April 10, 2016
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 TrialShinji Taneda, Jacob Hyllested-Winge, Mari-Anne Gall, et al.
Diabetes Care|October 28, 2003
Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetesThomas Danne, Kerstin Lüpke, Kerstin Walte, et al.
Diabetes Care|July 8, 2010
Vitamin D levels and mortality in type 2 diabetesChristel Joergensen, Mari-Anne Gall, Anne Schmedes, et al.
Diabetes Research and Clinical Practice|January 3, 2012
High YKL-40 levels predict mortality in patients with type 2 diabetesFrederik Persson, Camilla Noelle Rathcke, Mari-Anne Gall, et al.
Diabetes Care|October 9, 2010
Osteoprotegerin and mortality in type 2 diabetic patientsHenrik Reinhard, Maria Lajer, Mari-Anne Gall, et al.
Diabetes|March 28, 2002
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of deathCoen D A Stehouwer, Mari-Anne Gall, Jos W R Twisk, et al.
Obstetrics and Gynecology|September 5, 2024
Glycemic Control and Risk of Congenital Malformations in Women With Type 1 DiabetesIda Holte Thorius, Janne Petersen, Lise Lotte N Husemoen, et al.
Archives of Internal Medicine|October 13, 2006
Mannose-binding lectin and mortality in type 2 diabetesTroels Krarup Hansen, Mari-Anne Gall, Lise Tarnow, et al.
Pageof 3